# Evolocumab for Reducing MACE, Lead Exposure and CVD, AI Scribes for Clinicians, and more Page: https://stenobird.com/podcast/jama-editors-summary-786043/evolocumab-for-reducing-mace-lead-exposure-and-cvd-ai-scribes-for-clinicians-and-more Text version: https://stenobird.com/podcast/jama-editors-summary-786043/evolocumab-for-reducing-mace-lead-exposure-and-cvd-ai-scribes-for-clinicians-and-more.md Podcast: [JAMA Editors' Summary](https://stenobird.com/podcast/jama-editors-summary-786043) Published: 2026-04-03T15:05:00+00:00 Episode link: https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2026.4224 Audio file: https://traffic.libsyn.com/secure/jamaeditorsaudiosummary/Evolocumab_for_Reducing_MACE_Lead_Exposure_and_CVD_AI_Scribes_for_Clinicians_and_more_1.mp3?dest-id=90838 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/jama-editors-summary-786043/episodes/evolocumab-for-reducing-mace-lead-exposure-and-cvd-ai-scribes-for-clinicians-and-more Duration seconds: 990 ## Resource Editor's Summary by Linda Brubaker, MD, Preeti Malani, MD, MSJ, Deputy Editors of JAMA, and Gregory Curfman, MD, Executive Editor of the Journal of the American Medical Association, for articles published from March 28-April 3, 2026. Related Content: Audio Highlights ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/jama-editors-summary-786043/episodes/evolocumab-for-reducing-mace-lead-exposure-and-cvd-ai-scribes-for-clinicians-and-more/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/jama-editors-summary-786043/evolocumab-for-reducing-mace-lead-exposure-and-cvd-ai-scribes-for-clinicians-and-more.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.